Meteora Capital’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Meteora Capital’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,027	Closed	-$618	–	417
2023 Q3	$618	Buy	+11,027	New	+$1.32K	﹤0.01%	358

Meteora Capital's BIOSW Position: Q4 2023 in Review

Meteora Capital sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 11,027 shares — an estimated $618 sold.

Meteora Capital first reported a position in BIOSW in Q3 2023 and held it in 1 quarter. The position peaked at $618 in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Meteora Capital reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Meteora Capital sold 11,027 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $618.
Meteora Capital first reported a position in BioPlus Acquisition Corp. Warrants in Q3 2023 and held it in 1 quarter.
Meteora Capital's BioPlus Acquisition Corp. Warrants position peaked at $618 in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Meteora Capital's 13F filing for Q4 2023, filed 14 Feb 2024.